ClinVar Miner

Submissions for variant NM_058172.6(ANTXR2):c.211del (p.Glu71fs)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Neuberg Centre For Genomic Medicine, NCGM RCV003337920 SCV004048352 likely pathogenic Hyaline fibromatosis syndrome criteria provided, single submitter clinical testing The frameshift variant c.211del (p.Glu71ArgfsTer4) in ANTXR2 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Glu71ArgfsTer4 variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. This variant causes a frameshift starting with codon Glutamic Acid 71, changes this amino acid to Arginine residue, and creates a premature Stop codon at position 4 of the new reading frame, denoted p.Glu71ArgfsTer4. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Likely Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.